Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
218 results found
Feb 28, 2023
Publication
Collaborative
Nature Communications
COVID-19, Matrix-M® adjuvant
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
James Logue, Robert M. Johnson, Nita Patel, et al.
View
Feb 1, 2023
Publication
Novavax led
microorganisms
COVID-19, Matrix-M® adjuvant
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation
Plested JS, Zhu M, Cloney-Clark S, et al
View
Jan 25, 2023
Publication
Novavax led
Scientific Reports
COVID-19, Matrix-M® adjuvant
Immunogenicity of a fourth Homologous dose of NVX-CoV2373
Katia Alves, Joyce S. Plested, Shirley Galbiati, et al.
View
Jan 21, 2023
Publication
Collaborative
Scientific Reports
COVID-19, Matrix-M® adjuvant
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
View
Jan 19, 2023
Publication
Collaborative
Nature Communications
COVID-19, Matrix-M® adjuvant
Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial
Fong Y, Huang Y, Benkeser D, et al.
View
Jan 11, 2023
Publication
Novavax included/third party
The Lancet Regional Health – Southeast Asia
COVID-19, Matrix-M® adjuvant
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
Kulkarni PS, Kadam A, Godbole S, et al.
View
Nov 2, 2022
Publication
Novavax led
Vaccine
COVID-19
With established safe and effective use, protein vaccines offer another choice against COVID-19
Anthony M. Marchese, Hadi Beyhaghi, Walter A. Orenstein
View
Oct 24, 2022
Presentation
Novavax included/third party
COVID-19, Matrix-M® adjuvant
Safety and immunogenicity of a booster dose of Novavax COVID-19 vaccine, Adjuvanted (NVX-CoV2373) in adults from the PREVENT-19 trial in the United States
Germán Áñez, Lisa M. Dunkle, Cynthia L. Gay, et al.
View/Download
Oct 13, 2022
Presentation
Novavax led
COVID-19, Seasonal influenza
Update on Novavax Investigational Influenza vaccine and COVID-19-Influenza Combination Vaccine development
Vivek Shinde
View/Download
Oct 13, 2022
Presentation
Novavax led
COVID-19, Matrix-M® adjuvant
Paving the way for protein: Novavax’s COVID-19 vaccine as a booster and variant-adapted
Germán Áñez
View/Download